2003
DOI: 10.1016/s0306-4522(03)00285-9
|View full text |Cite
|
Sign up to set email alerts
|

Inhibiting cell proliferation during formation of the glial scar: effects on axon regeneration in the CNS

Abstract: Abstract-Following a CNS lesion many glial cell types proliferate and/or migrate to the lesion site, forming the glial scar. The majority of these cells express chondroitin sulphate proteoglycans (CS-PGs), previously shown to inhibit axonal growth. In this study, in an attempt to diminish glial scar formation and improve axonal regeneration, proliferating cells were eliminated from the lesion site. Adult rats received a continuous infusion of 2% cytosine-D-arabinofuranoside (araC) or saline for 7 days over the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
57
0
2

Year Published

2004
2004
2023
2023

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 73 publications
(61 citation statements)
references
References 67 publications
2
57
0
2
Order By: Relevance
“…The increased proliferation of activated microglia/macrophages at the lesion site after SCI in p53 Ϫ/Ϫ mice could lead to an aberrant inflammatory response, exacerbated secondary degeneration, and the formation of a more aggressive inhibitory environment, contributing to a more pronounced motor impairment. The inhibition of glial proliferation by several pharmacological strategies including the use of cell cycle inhibitors (Wu et al, 2011), such as Ara-C and Flavopiridol (Rhodes et al, 2003;Di Giovanni et al, 2005c;Byrnes et al, 2007), or the depletion of hematogenous macrophages by liposomeencapsulated clodronate (Popovich et al, 1999), has been shown to enhance axonal sprouting and functional recovery after both brain and spinal cord injury.…”
Section: Discussionmentioning
confidence: 99%
“…The increased proliferation of activated microglia/macrophages at the lesion site after SCI in p53 Ϫ/Ϫ mice could lead to an aberrant inflammatory response, exacerbated secondary degeneration, and the formation of a more aggressive inhibitory environment, contributing to a more pronounced motor impairment. The inhibition of glial proliferation by several pharmacological strategies including the use of cell cycle inhibitors (Wu et al, 2011), such as Ara-C and Flavopiridol (Rhodes et al, 2003;Di Giovanni et al, 2005c;Byrnes et al, 2007), or the depletion of hematogenous macrophages by liposomeencapsulated clodronate (Popovich et al, 1999), has been shown to enhance axonal sprouting and functional recovery after both brain and spinal cord injury.…”
Section: Discussionmentioning
confidence: 99%
“…To determine whether the AQP4-dependent astroglial cell migration in culture models might occur in the brain in vivo, we studied reactive gliosis and glial scar formation using a well-established cortical-stab-injury model (Bush et al, 1999;Hampton et al, 2004;Rhodes et al, 2003;Wang et al, 2004). The stab-injury mouse model, unlike other brain-injury models (tumor, infection, trauma), is not associated with significant brain swelling, which could confound interpretation of results.…”
Section: Reactive Gliosis In Vivomentioning
confidence: 99%
“…Astrocytes, derived from ependymal stem cells, migrate into the lesion to participate in glial scar formation after spinal cord injury in the adult . Proliferation of resident or migrating astrocytes is also involved in astrogliosis, but to a lesser extent (Rhodes et al, 2003;Hampton et al, 2004). Alterations in the intermediate filament cytoskeleton have been implicated in astrocyte motility.…”
Section: Glial Scar Formation and Mmp-2mentioning
confidence: 99%